Turning foes to friends: Advanced “in situ nanovaccine” with dual immunoregulation for enhanced immunotherapy of metastatic triple-negative breast cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Turning foes to friends: Advanced “in situ nanovaccine” with dual immunoregulation for enhanced immunotherapy of metastatic triple-negative breast cancer

Published:2024-09 Issue: Volume:39 Page:612-629
ISSN:2452-199X
Container-title:Bioactive Materials
language:en
Short-container-title:Bioactive Materials

Author:

Wang Ze,Sha Tong^ORCID,Li Jinwei,Luo Huanyu,Liu Annan,Liang Hao,Qiang Jinbiao^ORCID,Li Lei,Whittaker Andrew K.,Yang Bai,Sun Hongchen,Shi Ce,Lin Quan

Publisher

Elsevier BV

Reference45 articles.

1. Spatial predictors of immunotherapy response in triple-negative breast cancer;Wang;Nature,2023

2. c-Myc-Targeting PROTAC based on a TNA-DNA bivalent binder for combination therapy of triple-negative breast cancer;Li;J. Am. Chem. Soc.,2023

3. Tumor microenvironment: challenges and opportunities in targeting metastasis of triple negative breast cancer;Deepak;Pharmacol. Res.,2020

4. Triple-negative breast cancer molecular subtyping and treatment progress;Yin;Breast Cancer Res.,2020

5. Loading lovastatin into camptothecin-floxuridine conjugate nanocapsules for enhancing anti-metastatic efficacy of cocktail chemotherapy on triple-negative breast cancer;Zhang;Acs Appl. Mater. Inter.,2018

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Research trends on nanomaterials in triple negative breast cancer (TNBC): a bibliometric analysis from 2010 to 2024;Drug Delivery and Translational Research;2024-09-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP